Joseph Schulman1, Robert J Dimand2, Henry C Lee3, Grace V Duenas3, Mihoko V Bennett3, Jeffrey B Gould3. 1. California Department of Health Care Services, California Children's Services, Sacramento, California; joseph.schulman@dhcs.ca.gov. 2. California Department of Health Care Services, California Children's Services, Sacramento, California; 3. Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University, Stanford, California; and California Perinatal Quality Care Collaborative, Stanford, California.
Abstract
BACKGROUND AND OBJECTIVES: Treatment of suspected infection is a mainstay of the daily work in the NICU. We hypothesized that NICU antibiotic prescribing practice variation correlates with rates of proven infection, necrotizing enterocolitis (NEC), mortality, inborn admission, and with NICU surgical volume and average length of stay. METHODS: In a retrospective cohort study of 52,061 infants in 127 NICUs across California during 2013, we compared sample means and explored linear and nonparametric correlations, stratified by NICU level of care and lowest/highest antibiotic use rate quartiles. RESULTS: Overall antibiotic use varied 40-fold, from 2.4% to 97.1% of patient-days; median = 24.5%. At all levels of care, it was independent of proven infection, NEC, surgical volume, or mortality. Fifty percent of intermediate level NICUs were in the highest antibiotic use quartile, yet most of these units reported infection rates of zero. Regional NICUs in the highest antibiotic quartile reported inborn admission rate 218% higher (0.24 vs 0.11, P = .03), and length of stay 35% longer (90.2 days vs 66.9 days, P = .03) than regional NICUs in the lowest quartile. CONCLUSIONS: Forty-fold variation in NICU antibiotic prescribing practice across 127 NICUs with similar burdens of proven infection, NEC, surgical volume, and mortality indicates that a considerable portion of antibiotic use lacks clear warrant; in some NICUs, antibiotics are overused. Additional study is needed to establish appropriate use ranges and elucidate the determinants and directionality of relationships between antibiotic and other resource use.
BACKGROUND AND OBJECTIVES: Treatment of suspected infection is a mainstay of the daily work in the NICU. We hypothesized that NICU antibiotic prescribing practice variation correlates with rates of proven infection, necrotizing enterocolitis (NEC), mortality, inborn admission, and with NICU surgical volume and average length of stay. METHODS: In a retrospective cohort study of 52,061 infants in 127 NICUs across California during 2013, we compared sample means and explored linear and nonparametric correlations, stratified by NICU level of care and lowest/highest antibiotic use rate quartiles. RESULTS: Overall antibiotic use varied 40-fold, from 2.4% to 97.1% of patient-days; median = 24.5%. At all levels of care, it was independent of proven infection, NEC, surgical volume, or mortality. Fifty percent of intermediate level NICUs were in the highest antibiotic use quartile, yet most of these units reported infection rates of zero. Regional NICUs in the highest antibiotic quartile reported inborn admission rate 218% higher (0.24 vs 0.11, P = .03), and length of stay 35% longer (90.2 days vs 66.9 days, P = .03) than regional NICUs in the lowest quartile. CONCLUSIONS: Forty-fold variation in NICU antibiotic prescribing practice across 127 NICUs with similar burdens of proven infection, NEC, surgical volume, and mortality indicates that a considerable portion of antibiotic use lacks clear warrant; in some NICUs, antibiotics are overused. Additional study is needed to establish appropriate use ranges and elucidate the determinants and directionality of relationships between antibiotic and other resource use.
Authors: Joseph Schulman; David Braun; Henry C Lee; Jochen Profit; Grace Duenas; Mihoko V Bennett; Robert J Dimand; Maria Jocson; Jeffrey B Gould Journal: JAMA Pediatr Date: 2018-01-01 Impact factor: 16.193
Authors: Emily J Godbout; Amy L Pakyz; John Daniel Markley; Andrew J Noda; Michael P Stevens Journal: Curr Infect Dis Rep Date: 2018-08-01 Impact factor: 3.725
Authors: Jeffrey R Singer; Emily G Blosser; Carlene L Zindl; Daniel J Silberger; Sean Conlan; Vincent A Laufer; Daniel DiToro; Clay Deming; Ranjit Kumar; Casey D Morrow; Julia A Segre; Michael J Gray; David A Randolph; Casey T Weaver Journal: Nat Med Date: 2019-11-07 Impact factor: 53.440
Authors: Daniel S Tawfik; John Bryan Sexton; Kathryn C Adair; Heather C Kaplan; Jochen Profit Journal: Clin Perinatol Date: 2017-07-08 Impact factor: 3.430
Authors: Sagori Mukhopadhyay; Karen M Puopolo; Nellie I Hansen; Scott A Lorch; Sara B DeMauro; Rachel G Greenberg; C Michael Cotten; Pablo J Sánchez; Edward F Bell; Eric C Eichenwald; Barbara J Stoll Journal: J Pediatr Date: 2020-06 Impact factor: 4.406
Authors: Timmy Ho; Madge E Buus-Frank; Erika M Edwards; Kate A Morrow; Karla Ferrelli; Arjun Srinivasan; Daniel A Pollock; Dmitry Dukhovny; John A F Zupancic; DeWayne M Pursley; Roger F Soll; Jeffrey D Horbar Journal: Pediatrics Date: 2018-12 Impact factor: 7.124